{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:01:54Z","timestamp":1787169714942,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"\n \n \n The use of cardiovascular implantable electronic devices (CIED) is associated with improved quality of life and decreased fatal outcomes in patients with cardiac dysfunctions. As with all foreign devices that are inserted or implanted in the body, CIED also carries the risk of device-related infections. Infections account for <2% of the complications associated with CIED, and only about 2% of these are secondary to a fungal pathogen. The first case of\n Aspergillus<\/jats:italic>\n endocarditis secondary to a transvenous pacing lead was reported in the 1980s, and a limited number of cases have been documented in the literature since then.\n Aspergillus<\/jats:italic>\n endocarditis is a highly fatal disease and establishing the diagnosis sufficiently early is challenging. We here report a case of\n Aspergillus<\/jats:italic>\n endocarditis secondary to permanent pacemaker insertion which was successfully treated following the establishment of the diagnosis using imaging studies and galactomannan assay.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jgid.jgid_67_21","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T04:29:02Z","timestamp":1635827342000},"page":"38-40","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A Case of Pacemaker Associated Aspergillus fumigatus Endocarditis"],"prefix":"10.4103","volume":"14","author":[{"given":"Ujjwayini","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20240828","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.3109\/13693786.2010.498449","article-title":"Aspergillus endocarditis 2003-2009","volume":"49","author":"McCormack","year":"2011","journal-title":"Med Mycol"},{"key":"R2-8-20240828","doi-asserted-by":"crossref","first-page":"65","DOI":"10.15420\/aer.2015.27.2","article-title":"Cardiac implantable electronic device infection in patients at risk","volume":"5","author":"Tarakji","year":"2016","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"R3-8-20240828","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3949\/ccjm.84.s3.05","article-title":"Cardiac implantable electronic device infection","volume":"84","author":"Lambert","year":"2017","journal-title":"Cleve Clin J Med"},{"key":"R4-8-20240828","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/heartjnl-2012-301627","article-title":"Long-term outcomes following infection of cardiac implantable electronic devices: A prospective matched cohort study","volume":"98","author":"Deharo","year":"2012","journal-title":"Heart"},{"key":"R5-8-20240828","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.109.192665","article-title":"Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association","volume":"121","author":"Baddour","year":"2010","journal-title":"Circulation"},{"key":"R6-8-20240828","first-page":"152","article-title":"Incidence and outcome of documented fungal endocarditis","volume":"8","author":"Badiee","year":"2014","journal-title":"Int Cardiovasc Res J"},{"key":"R7-8-20240828","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1128\/CMR.14.1.177-207.2001","article-title":"Endocarditis due to rare and fastidious bacteria","volume":"14","author":"Brouqui","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"R8-8-20240828","doi-asserted-by":"crossref","first-page":"e0201459","DOI":"10.1371\/journal.pone.0201459","article-title":"Aspergillus endocarditis: Diagnostic criteria and predictors of outcome, A retrospective cohort study","volume":"13","author":"Meshaal","year":"2018","journal-title":"PLoS One"},{"key":"R9-8-20240828","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1086\/592977","article-title":"Galactomannan detection as a tool for the diagnosis and management of cardiac aspergillosis in 2 immunocompetent patients","volume":"47","author":"Garc\u00eda-Rodr\u00edguez","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R10-8-20240828","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/mmy\/myu017","article-title":"Evaluation of noninvasive methods for the diagnosis of fungal endocarditis","volume":"52","author":"Badiee","year":"2014","journal-title":"Med Mycol"}],"container-title":["Journal of Global Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jgid.jgid_67_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:10:57Z","timestamp":1787166657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jgid.jgid_67_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jgid.jgid_67_21","relation":{},"ISSN":["0974-777X"],"issn-type":[{"value":"0974-777X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}